Published in AIDS on February 18, 2005
Comparative analysis of 22 coronavirus HKU1 genomes reveals a novel genotype and evidence of natural recombination in coronavirus HKU1. J Virol (2006) 1.87
Human cytomegalovirus intrahost evolution-a new avenue for understanding and controlling herpesvirus infections. Curr Opin Virol (2014) 0.90
Mixed infections with distinct cytomegalovirus glycoprotein B genotypes in Polish pregnant women, fetuses, and newborns. Eur J Clin Microbiol Infect Dis (2014) 0.81
Chronic lymphocytic leukemia patients have a preserved cytomegalovirus-specific antibody response despite progressive hypogammaglobulinemia. PLoS One (2013) 0.78
High genotypic diversity and a novel variant of human cytomegalovirus revealed by combined UL33/UL55 genotyping with broad-range PCR. Virol J (2009) 0.77
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. J Infect Dis (2005) 3.52
Preexposure prophylaxis and timed intercourse for HIV-discordant couples willing to conceive a child. AIDS (2011) 3.26
Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Infect Dis (2009) 2.60
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach. Retrovirology (2009) 1.58
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics. Retrovirology (2013) 1.30
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes. J Acquir Immune Defic Syndr (2006) 1.27
Acute encephalopathy associated with influenza A virus infection. Clin Infect Dis (2003) 1.25
Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time. J Virol (2010) 1.23
Viral features of lamivudine resistant hepatitis B genotypes A and D. Hepatology (2004) 1.13
Diagnosis of herpesvirus infections of the central nervous system. J Clin Virol (2002) 1.13
Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection. Clin Immunol (2002) 1.12
Genotypic prediction of human immunodeficiency virus type 1 tropism by use of plasma and peripheral blood mononuclear cells in the routine clinical laboratory. J Clin Microbiol (2011) 1.03
The impact of PCR-generated recombination on diversity estimation of mixed viral populations by deep sequencing. J Virol Methods (2010) 1.03
Limited cross-border infections in patients newly diagnosed with HIV in Europe. Retrovirology (2013) 1.01
Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART). J Clin Virol (2006) 0.97
Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection. J Med Virol (2005) 0.96
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infect Dis (2014) 0.96
Increased blood phenylalanine to tyrosine ratio in HIV-1 infection and correction following effective antiretroviral therapy. Brain Behav Immun (2009) 0.96
Analysis of the variability of CMV strains in the RL11D domain of the RL11 multigene family. Virus Genes (2007) 0.95
Quantitative real time PCR detection of Varicella-zoster virus DNA in cerebrospinal fluid in patients with neurological disease. Med Microbiol Immunol (2004) 0.95
Low proportion of recent human immunodeficiency virus (HIV) infections among newly diagnosed cases of HIV infection as shown by the presence of HIV-specific antibodies of low avidity. J Clin Microbiol (2005) 0.90
Virus load dynamics of individual CMV-genotypes in lung transplant recipients with mixed-genotype infections. J Med Virol (2008) 0.88
Human granulocytic anaplasmosis in Austria: epidemiological, clinical, and laboratory findings in five consecutive patients from Tyrol, Austria. Int J Med Microbiol (2006) 0.87
Human cytomegalovirus (HCMV) genotype populations in immunocompetent individuals during primary HCMV infection. J Clin Virol (2010) 0.86
Genotypic antiretroviral resistance testing for human immunodeficiency virus type 1 integrase inhibitors by use of the TruGene sequencing system. J Clin Microbiol (2008) 0.85
Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes. Virus Res (2006) 0.84
Asymmetric dimethylarginine concentrations decrease in patients with HIV infection under antiretroviral therapy. Antivir Ther (2012) 0.84
High prevalence of high risk human papillomavirus-capsid antibodies in human immunodeficiency virus-seropositive men: a serological study. BMC Infect Dis (2003) 0.83
HIV coreceptor tropism in antiretroviral treatment-naive patients newly diagnosed at a late stage of HIV infection. AIDS (2010) 0.83
TTV DNA plasma load and its association with age, gender, and HCMV IgG serostatus in healthy adults. Age (Dordr) (2014) 0.83
Age-dependent increase of memory B cell response to cytomegalovirus in healthy adults. Exp Gerontol (2012) 0.83
Cytomegalovirus DNA load patterns developing after lung transplantation are significantly correlated with long-term patient survival. Transplantation (2009) 0.83
Association of cytomegalovirus DNA concentration in epithelial lining fluid and symptomatic cytomegalovirus infection in lung transplant recipients. Transplantation (2004) 0.82
Interferon-gamma-mediated pathways and in vitro PBMC proliferation in HIV-infected patients. Biol Chem (2009) 0.82
Chronic hepatitis E infection in lung transplant recipients. J Heart Lung Transplant (2013) 0.80
Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection. Adv Exp Med Biol (2003) 0.79
Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment. J Clin Microbiol (2006) 0.79
A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin. Antivir Ther (2012) 0.79
Detection of human cytomegalovirus in bronchoalveolar lavage fluid of lung transplant recipients reflects local virus replication and not contamination from the throat. J Clin Microbiol (2010) 0.78
German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008. Eur J Med Res (2009) 0.78
Chronic lymphocytic leukemia patients have a preserved cytomegalovirus-specific antibody response despite progressive hypogammaglobulinemia. PLoS One (2013) 0.78
Association of HCMV specific IgG subclass antibody levels with gender and age. Exp Gerontol (2013) 0.76
Associations among Epstein-Barr virus subtypes, human leukocyte antigen class I alleles, and the development of posttransplantation lymphoproliferative disorder in bone marrow transplant recipients. Clin Infect Dis (2007) 0.76
HIV microarray for the mapping and characterization of HIV-specific antibody responses. Lab Chip (2015) 0.75
Primary cytomegalovirus infection in patients with Guillain-Barré syndrome. J Neuroimmunol (2006) 0.75
Torque Teno Virus Load-Inverse Association With Antibody-Mediated Rejection After Kidney Transplantation. Transplantation (2017) 0.75
Is the poorer rate of survival among patients with human immunodeficiency virus infection and anemia linked to immune activation? J Infect Dis (2002) 0.75
Antiretroviral drugs and the risk of myocardial infarction. N Engl J Med (2007) 0.75
Seroconversion and avidity maturation of cytomegalovirus-specific IgG in D+/R- lung transplant patients receiving different prophylactic anti-viral regimens. J Heart Lung Transplant (2012) 0.75
Standardisation and controls, why can't we overcome the hurdles? J Clin Virol (2004) 0.75
Thyroid screening in HIV-infected patients with antiretroviral therapy. Wien Klin Wochenschr (2015) 0.75
Intrapulmonary Human Cytomegalovirus Replication in Lung Transplant Recipients Is Associated With a Rise of CCL-18 and CCL-20 Chemokine Levels. Transplantation (2017) 0.75
Parameters of soluble immune activation in vivo correlate negatively with the proliferative capacity of peripheral blood mononuclear cells in vitro in HIV-infected patients. J Acquir Immune Defic Syndr (2009) 0.75
Absence of human immunodeficiency virus infection after intentional injection of infected blood. Clin Infect Dis (2002) 0.75